Annual report pursuant to Section 13 and 15(d)

LOSS PER SHARE

v3.10.0.1
LOSS PER SHARE
12 Months Ended
Nov. 30, 2018
LOSS PER SHARE [Text Block]

NOTE 14 – LOSS PER SHARE

The following table sets forth the calculation of basic and diluted loss per share for the periods indicated:

 

    Year Ended  
    November 30,  
    2018     2017  
    (in thousands,  
    except per share data)  
Basic:            
   Net loss attributable to Orgenesis Inc $ 18,291   $ 12,367  
   Adjustment of redeemable non-controlling interest to redemption amount   884     -  
   Net loss attributable to Orgenesis Inc. for loss per share $ 19,175   $ 12,367  
   Weighted average number of common shares outstanding   13,374,103     9,679,964  
   Basic loss per common share $ 1.43   $ 1.28  
Diluted :            
   Net loss attributable to Orgenesis Inc. for loss per share $ 19,175     12,367  
   Changes in fair value of embedded derivative and interest expenses on convertible note   -     392  
   Loss for the year $ 19,175   $ 12,759  
             
   Weighted average number of shares used in the computation of basic loss per share   13,374,103     9,679,964  
   Number of dilutive shares related to convertible note   -     34,288  
   Weighted average number of common shares outstanding   13,374,103     9,714,252  
             
Diluted loss per common share $ 1.43   $ 1.31  

For the year ended November 30, 2018, all outstanding convertible notes, options and warrants have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive.

     For the year ended November 30, 2017, all outstanding options and warrants and 1,057,785 shares upon conversion of convertible notes have been excluded from the calculation of the diluted net loss per share since their effect was anti-dilutive.